Polysaccharide derivatives and uses in induction of an immune response
View Patent ↗The present invention generally provides compositions comprising a polysaccharide derivative, and methods of their preparation and use for the prevention or treatment of diseases caused by Neisseria meningitidis bacteria, particularly group B (NmB) strains, and by E. coli K1. The invention provides a de-N-acetylated PS derivative in which one or more residues of the PS has been modified by de-N-acetylation. The invention also includes derivatives in which one or more of the N-acetyl groups of PS containing de-N-acetylated PS are replaced with other N-acyl groups, usually a lower acyl group of C 2 -C 3 . Further, the invention includes de-N-acetylated PS derivatives containing long chain hydrocarbons, as well as conjugates in which the de-N-acetylated PS derivative is linked to a carrier, e.g., a carrier protein.
1. A composition comprising an adjuvant and a de-N-acetylated polysaccharide (PS) derivative, wherein the de-N-acetylated PS derivative is a polysialic acid heteropolymer comprising residues of N-acetyl sialic acid, de-N-acetyl sialic acid having a free amine, and re-N-acylated sialic acid having an amine protecting group other than acetyl, and wherein said heteropolymer further comprises a minimum of about 20% N-acetyl sialic acid residues and a least one dimer comprising an N-acetyl sialic acid residue and a de-N-acetyl sialic acid residue having a free amine.
2. A composition comprising a de-N-acetylated polysaccharide (PS) derivative comprising a heteropolymer of N-acetyl sialic acid, de-N-acetyl sialic acid having a free amine, and re-N-acylated sialic acid having an amine protecting group other than acetyl, and a structure represented by the formula:
wherein
X and Y are independently H, an acetyl group, or an amine protecting group other than acetyl; and
n is at least 1;
wherein the de-N-acetylated PS derivative is conjugated to a carrier protein or further comprises a sialic acid residue having an alkyl secondary amine at a non-reducing end of the de-N-acetylated PS derivative; and
wherein the de-N-acetylated PS derivative comprises a minimum of about 20% N-acetyl sialic acid residues and at least one dimer comprising a de-N-acetyl sialic acid residue and an N-acetyl-sialic acid residue.
3. A composition comprising a polysaccharide (PS) derivative comprising a structure represented by the formula:
wherein
X, Y and Z are independently H or a saturated acyl group, with the proviso that at least one of X, Y, and Z is H, at least one of X, Y, and Z is a saturated acyl group; and n is at least one; wherein the PS derivative is optionally conjugated to a carrier protein or further comprises a sialic acid residue having an alkyl secondary amine at a non-reducing end of the PS derivative,
wherein said PS derivative further comprises a minimum of about 20% N-acetyl sialic acid residues and at least one dimer comprising an N-acetyl sialic acid residue and a de-N-acetyl sialic acid residue having a free amine.
4. The composition of claim 3 , wherein when two of X, Y, and Z are acyl groups, the acyl groups are different acyl groups.
5. The composition of claim 4 , wherein at least one of X, Y, and Z is an acetyl group and at least one of X, Y, and Z is a propionyl group.
6. The composition of claim 3 , wherein when X is H, Y and Z are different acyl groups; when X is an acyl group, Y and Z are different moieties and are either H or a an acyl group; and when X is an acyl group, Y and Z are different moieties and are either H or an acyl group.
7. The composition of claim 6 , wherein
when X is H, Y and Z are different acyl groups selected from acetyl and propionyl;
when X is an acetyl group, Y and Z are different moieties and are either H or a propionyl group; and
when X is a propionyl group, Y and Z are different moieties and are either H or an acetyl group.
8. The composition of claim 3 , wherein the PS derivative comprises an amidated sialic acid residue having an alkyl secondary amine at a non-reducing terminus of the PS derivative.
9. The composition of any one of claims 1 - 2 , wherein the de-N-acetylated PS derivative is conjugated to a carrier protein.
10. The compositions of any one of claims 1 - 3 , wherein the PS derivative comprises a sialic acid residue derivative having a lactone moiety or a cyclic secondary amine.
11. A composition comprising a de-N-acetylated polysaccharide (PS) derivative comprising a heteropolymer of de-N-acetyl sialic acid residues, N-acetyl sialic acid residues, and re-N-acylated sialic acid residues having an amine protecting group other than acetyl, and a structure represented by the formula:
wherein
X and Y are independently an amine protecting group, or a saturated or unsaturated acyl group; and
n is at least 1;
wherein the de-N-acetylated PS derivative optionally further comprises a carrier protein conjugated to a sialic acid residue of the de-N-acetylated PS derivative, or optionally further comprises an amidated sialic acid residue having an alkyl secondary amine at a non-reducing end of the de-N-acetylated PS derivative; and
wherein the de-N-acetylated PS derivative comprises a minimum of about 20% N-acetyl sialic acid residues and at least one dimer comprising a de-N-acetyl sialic acid residue and an N-acetyl sialic acid residue.
12. The composition of claim 11 , wherein the acyl group is a saturated acyl group selected from acetyl or propionyl.
13. The composition of claim 11 , wherein the PS derivative comprises a structure represented by the formula:
wherein
X, Y and Z are independently an amine protecting group, with the proviso that at least one of X, Y, and Z is an amine protecting group and at least one of X, Y, and Z is a saturated or unsaturated acyl group; and
n is at least one.
14. The composition of claim 13 , wherein the acyl group is a saturated acyl group and acetyl or propionyl.
15. A method of immunizing a subject, comprising:
administering to a subject an amount of a PS derivative of claim 1 in an amount effective to elicit an immune response;
wherein said administering is effective to elicit an immune response in the subject against Neisseria meningitidis group B.
16. A method of immunizing a subject, comprising:
administering to a subject an amount of a PS derivative of claim 1 in an amount effective to elicit an immune response;
wherein said administering is effective to elicit an immune response in the subject against Escherichia coli K1.
17. A method for providing passive protection against a bacterial infection, the method comprising:
administering to a subject bactericidal antibodies elicited by immunization of a host with the de-N-acetylated PS derivative of any of claim 1 ;
wherein said administering provides for protection of the subject against Neisseria meningitidis group B or against Escherichia coli K1.
18. The composition of claim 1 , wherein the PS derivative comprises a structure represented by the formula:
wherein X, Y and Z are independently H, or a saturated or unsaturated acyl group;
n is at least 1;
R 1 is a saturated or unsaturated acyl amine; and
R 2 is a hydroxyl , one or more acylated amines, a de-N-acetylated sialic acid residue, or a polymer of de-N-acetylated sialic acid residues and acylated sialic acid residues.
19. The composition of claim 18 , wherein R 2 is polymer of a de-N-acetylated sialic acid residues and sialic acid residues; wherein said sialic acid residues are acetylated sialic acid residues, propionylated sialic acid residues or a combination thereof.
20. The composition of claim 1 , wherein the PS derivative comprises a structure represented by the formula:
wherein X 1 , X, Y and Z are independently H, or a saturated or unsaturated acyl group;
n is at least 1;
R 1 is a saturated or unsaturated acyl amine; and
R 2 is a hydroxyl, one or more acylated amines, a de-N-acetylated sialic acid residue, or polymer of de-N-acetylated sialic acid residues and acylated sialic acid residues.
21. The composition of claim 20 , wherein R 2 is polymer of a de-N-acetylated sialic acid residues and sialic acid residues; wherein said sialic acid residues are acetlylated sialic acid residues, propionylated sialic acid residues or a combination thereof.
22. The composition of claim 18 wherein:
when X is H, Y and Z are different acyl groups selected from acetyl and propionyl;
when X is an acetyl group, Y and Z are different moieties and are either H or a propionyl group; and
when X is a propionyl group, Y and Z are different moieties and are either H or an acetyl group.
23. A composition comprising an adjuvant and a de-N-acetylated polysaccharide (PS) derivative, wherein the de-N-acetylated PS derivative comprises residues of N-acetyl sialic acid and de-N-acetyl sialic acid having a free amine, a minimum of about 20% N-acetyl sialic acid residues, and a least one dimer comprising a N-acetyl sialic acid residue and a de-N-acetyl sialic acid residue having a free amine; and
wherein the de-N-acetylated PS derivative comprises a structure represented by the formula:
wherein n is at least 1;
X and Y are independently H, or a saturated or unsaturated acyl group;
R 1 and R 2 are independently H, or a saturated or unsaturated acyl group; and
wherein the de-N-acetylated PS derivative is further modified to include a carrier protein and/or an acyl amine.
24. The composition of claim 23 , wherein n is at least 2, X is an acetyl group, Y is an acetyl group, R 1 is H, and R 2 is an acetyl group.
25. The composition of claim 24 , wherein the de-N-acetylated PS derivative is further modified to include a carrier protein.
26. A composition comprising an adjuvant and a de-N-acetylated polysaccharide (PS) derivative conjugated to a carrier protein, wherein the de-N-acetylated PS derivative is a polysialic acid heteropolymer that comprises residues of N-acetyl sialic acid and de-N-acetyl sialic acid having a free amine, a minimum of about 20% N-acetyl sialic acid residues, and a least one dimer comprising an N-acetyl sialic acid residue and a de-N-acetyl sialic acid residue having a free amine.
27. The composition of claim 26 , wherein the carrier protein is conjugated to the non-reducing end of the de-N-acetylated PS derivative.
28. The composition of claim 26 , wherein the dimer comprising an N-acetyl sialic acid residue and a de-N-acetyl sialic acid residue having a free amine is at the non-reducing end of the de-N-acetylated PS derivative.
29. The composition of claim 26 , wherein the de-N-acetylated PS derivative comprises a re-N-acylated sialic acid residue having an amine protecting group other than acetyl.
30. The composition of claim 26 , wherein the de-N-acetylated PS derivative has degree of polymerization of about 2 to about 60.
31. The composition of claim 26 , wherein the de-N-acetylated PS derivative has degree of polymerization of about 2 to about 10.
32. The composition of claim 1 , wherein said de-N-acetylated PS derivative comprises an epitope recognized by the antibody SEAM 3.
33. The composition of claim 2 , wherein said de-N-acetylated PS derivative comprises an epitope recognized by the antibody SEAM 3.
34. The composition of claim 11 , wherein said de-N-acetylated PS derivative comprises an epitope recognized by the antibody SEAM 3.
35. The composition of claim 23 , wherein said de-N-acetylated PS derivative comprises an epitope recognized by the antibody SEAM 3.
36. The composition of claim 26 , wherein said de-N-acetylated PS derivative comprises an epitope recognized by the antibody SEAM 3.